Volume 25, Issue 4, Pages (October 2006)

Slides:



Advertisements
Similar presentations
Volume 28, Issue 4, Pages (November 2007)
Advertisements

3-Dimensional structure of membrane-bound coagulation factor VIII: modeling of the factor VIII heterodimer within a 3-dimensional density map derived by.
Volume 97, Issue 6, Pages (June 1999)
Volume 8, Issue 12, Pages (December 2000)
Crystal Structure of the Tandem Phosphatase Domains of RPTP LAR
Volume 9, Issue 2, Pages (February 2002)
A Fence-like Coat for the Nuclear Pore Membrane
Structure of the Forkhead Domain of FOXP2 Bound to DNA
Volume 27, Issue 4, Pages (October 2007)
Volume 11, Issue 6, Pages (June 2003)
Sebastian Meyer, Raimund Dutzler  Structure 
Kristopher Josephson, Naomi J. Logsdon, Mark R. Walter  Immunity 
Structure of an LDLR-RAP Complex Reveals a General Mode for Ligand Recognition by Lipoprotein Receptors  Carl Fisher, Natalia Beglova, Stephen C. Blacklow 
Volume 124, Issue 1, Pages (January 2006)
Atomic Model of CPV Reveals the Mechanism Used by This Single-Shelled Virus to Economically Carry Out Functions Conserved in Multishelled Reoviruses 
Volume 26, Issue 3, Pages (March 2007)
Volume 31, Issue 1, Pages (July 2009)
Structural Basis for the Specific Recognition of Methylated Histone H3 Lysine 4 by the WD-40 Protein WDR5  Zhifu Han, Lan Guo, Huayi Wang, Yue Shen, Xing.
Chaperone-Assisted Crystallography with DARPins
Decoy Strategies: The Structure of TL1A:DcR3 Complex
Tamas Yelland, Snezana Djordjevic  Structure 
Volume 34, Issue 4, Pages (May 2009)
Mark Ultsch, Nathalie A Lokker, Paul J Godowski, Abraham M de Vos 
Volume 23, Issue 7, Pages (July 2015)
Structure of the Endonuclease Domain of MutL: Unlicensed to Cut
Structure and T Cell Inhibition Properties of B7 Family Member, B7-H3
Volume 28, Issue 4, Pages (November 2007)
Volume 13, Issue 5, Pages (November 2000)
Volume 22, Issue 1, Pages (January 2005)
Volume 15, Issue 1, Pages (January 2007)
Molecular Basis of Lysosomal Enzyme Recognition: Three-Dimensional Structure of the Cation-Dependent Mannose 6-Phosphate Receptor  David L Roberts, Daniel.
Volume 19, Issue 12, Pages (December 2011)
Crystal Structures of Oligomeric Forms of the IP-10/CXCL10 Chemokine
Solution and Crystal Structures of a Sugar Binding Site Mutant of Cyanovirin-N: No Evidence of Domain Swapping  Elena Matei, William Furey, Angela M.
Volume 31, Issue 2, Pages (July 2008)
Volume 4, Issue 5, Pages (November 1999)
Volume 23, Issue 6, Pages (December 2005)
Volume 20, Issue 3, Pages (March 2004)
Structural Insights into the Inhibition of Wnt Signaling by Cancer Antigen 5T4/Wnt- Activated Inhibitory Factor 1  Yuguang Zhao, Tomas Malinauskas, Karl.
Crystal Structure of Recombinant Human Interleukin-22
Volume 11, Issue 6, Pages (June 2003)
Volume 124, Issue 5, Pages (March 2006)
Volume 18, Issue 8, Pages (August 2010)
Volume 11, Issue 2, Pages (August 1999)
Structure of the Cathelicidin Motif of Protegrin-3 Precursor
Zhenjian Cai, Nabil H. Chehab, Nikola P. Pavletich  Molecular Cell 
The Crystal Structure of the Costimulatory OX40-OX40L Complex
Daniel Peisach, Patricia Gee, Claudia Kent, Zhaohui Xu  Structure 
Volume 2, Issue 8, Pages (August 1994)
Volume 9, Issue 11, Pages (November 2001)
Volume 91, Issue 5, Pages (November 1997)
Antonina Roll-Mecak, Chune Cao, Thomas E. Dever, Stephen K. Burley 
Volume 101, Issue 4, Pages (May 2000)
What Does It Take to Bind CAR?
Structural Basis for FGF Receptor Dimerization and Activation
Volume 15, Issue 6, Pages (December 2001)
Mechanisms Contributing to T Cell Receptor Signaling and Assembly Revealed by the Solution Structure of an Ectodomain Fragment of the CD3ϵγ Heterodimer 
Volume 11, Issue 2, Pages (February 2003)
Volume 11, Issue 4, Pages (April 2003)
Crystal Structure of the Human Myeloid Cell Activating Receptor TREM-1
Volume 91, Issue 5, Pages (November 1997)
Volume 13, Issue 5, Pages (May 2005)
Structure of CD94 Reveals a Novel C-Type Lectin Fold
Volume 14, Issue 3, Pages (March 2006)
Structure of an IκBα/NF-κB Complex
Kristopher Josephson, Naomi J. Logsdon, Mark R. Walter  Immunity 
Volume 7, Issue 12, Pages (January 1999)
Crystal Structure of the Human Neuropilin-1 b1 Domain
Structural Basis for Activation of ARF GTPase
Structure of GABARAP in Two Conformations
Presentation transcript:

Volume 25, Issue 4, Pages 559-570 (October 2006) NTB-A Receptor Crystal Structure: Insights into Homophilic Interactions in the Signaling Lymphocytic Activation Molecule Receptor Family  Erhu Cao, Udupi A. Ramagopal, Alexander Fedorov, Elena Fedorov, Qingrong Yan, Jeffrey W. Lary, James L. Cole, Stanley G. Nathenson, Steven C. Almo  Immunity  Volume 25, Issue 4, Pages 559-570 (October 2006) DOI: 10.1016/j.immuni.2006.06.020 Copyright © 2006 Elsevier Inc. Terms and Conditions

Figure 1 Organization of the NTB-A Monomer (A) The NTB-A ectodomain consists of membrane-distal IgV and membrane-proximal IgC2 domains. The β strands are labeled and the potential N-glycosylation sites are highlighted. (B) The interdomain interface is stabilized by a number of van der Waals interactions and an invariant hydrogen bond involving Asn-177 ND2 and the main-chain oxygen of Arg-106 (black dash line). Asn-177 OD1 also forms potential hydrogen bonds with main-chain nitrogen atoms in the FG loop. Immunity 2006 25, 559-570DOI: (10.1016/j.immuni.2006.06.020) Copyright © 2006 Elsevier Inc. Terms and Conditions

Figure 2 Organization of the NTB-A Homophilic Dimer (A) The NTB-A dimer is composed of two monomers, shown as blue and red, which interact in a nearly orthogonal fashion and result in an end-to-end distance of ∼100 Å. (B) Expanded view along the local two-fold symmetry axis of the interface, showing the orthogonal association of the front β sheets with predominant contributions from the C, C′, C′′, and F strands of each monomer. (C) Detailed view of the NTB-A homophilic interface. In the left panel, residues forming hydrogen bonds, as well as Phe-42 that marks the approximate center, are shown at same orientation as (B); hydrogen bonds are represented by dashed lines. In the right panel, the dimer is rotated ∼180° along the indicated axis so that the hydrophobic interactions involving aromatic residues at the interface are best illustrated. (D) Alignment of NTB-A ectodomain sequences. The conserved residues are shaded red, and residues with similar properties are labeled red. Residues involved in homophilic and interdomain interactions are denoted “∗” and “○”, respectively. The β strands are denoted as underlined segments in the human sequence and labeled with black (IgV) and red (IgC2) letters. Immunity 2006 25, 559-570DOI: (10.1016/j.immuni.2006.06.020) Copyright © 2006 Elsevier Inc. Terms and Conditions

Figure 3 Structural Comparisons of NTB-A and Other CD2 Family Members (A) Superposition of IgV domains of CD2, NTB-A, 2B4, and CD58. The loops exhibiting significant diversity are highlighted; the C′C′′ and CC′ loops are labeled with arrows and arrowheads, respectively. (B) Comparison of the IgC2 domains of NTB-A and CD2. The loops that exhibit significant structural deviations are indicated: the AB, C′E, and EF loops are denoted by black arrows, pink arrowheads, and black arrowheads, respectively. Disulfide bonds are highlighted as magenta sticks. (C) The difference in the NTB-A and CD2 interdomain angle is highlighted by superposition of the IgV domains, and such superposition results in a significant deviation in the placement of IgC2 domains. Immunity 2006 25, 559-570DOI: (10.1016/j.immuni.2006.06.020) Copyright © 2006 Elsevier Inc. Terms and Conditions

Figure 4 Oligomeric States of the Wild-Type and S90A NTB-A Ectodomains (A) Elution profile of the human NTB-A ectodomain from Superdex G200. The single monodisperse peak at 14.7 ml corresponds to a MW between 43 and 67 kD. (B) g(s∗) analysis of the wild-type NTB-A by sedimentation velocity. Protein concentration ranges from 0.14–1.38 mg/ml. (C) g(s∗) analysis of S90A by sedimentation velocity. Protein concentration ranges from 0.17–1.48 mg/ml. Immunity 2006 25, 559-570DOI: (10.1016/j.immuni.2006.06.020) Copyright © 2006 Elsevier Inc. Terms and Conditions

Figure 5 Comparsion of Homophilic and Heterophilic Interfaces (A and C) The overall organization of NTB-A homophilic and CD2-CD58 heterophilic dimers. One NTB-A molecule (blue) and CD58 (blue) are displayed in the same orientation, highlighting the detailed differences in overall organization of the two dimers. Residues contributing to the two interfaces are highlighted yellow. (B) Detailed view of the NTB-A homophilic interface. The blue monomer is rotated ∼180° about a horizontal axis relative to (A) so that the residues that contribute to the binding surface are exposed. The labels of individual residues are color coded blue, red, and black to represent basic, acidic, and neutral residues, respectively. (D) Residues contributing to the CD2-CD58 interface displayed as in (C). The significant contribution of loop residues and charged residues, relative to NTB-A, is demonstrated. (E) Alignment of the CD2-family ectodomain sequences. The strictly conserved residues are shaded red, and residues with similar properties are labeled red. Residues critical for homophilic interactions in NTB-A are denoted with “∗”, residues involved in CD2-CD58 heterophilic interaction are denoted with black “#” (CD2) and blue “#” (CD58), and residues contributing to the interdomain interface in NTB-A and CD2 are denoted with “○”. Ly-9 Arg-44 is underlined in green. The β strands identified from existing structures are underlined in black, and labeled with black (IgV) or red (IgC2) capital letters. Potential N-glycosylation sites in the AB and EF loops in the IgC2 domains are underlined red. Immunity 2006 25, 559-570DOI: (10.1016/j.immuni.2006.06.020) Copyright © 2006 Elsevier Inc. Terms and Conditions

Figure 6 Functional Implications of the NTB-A Structure Homophilic engagement of NTB-A may trigger recruitment of the NTB-A to the immunological synapse. The linear dimensions of the NTB-A dimer are similar to those of other molecular signaling pairs involved in T cell regulation, consistent with a sorting mechanism based on molecular extent. In T cells, the local enrichment of NTB-A and its associated signaling components, including SAP and FynT, initiates the downstream signaling events that culminate in modulation of IFN-γ secretion and stimulation of Th2 responses. In APCs, EAT-2-coupled signaling cascades are similarly activated upon NTB-A homophilic engagement, although all of the analogous signaling molecules remain to be identified. Immunity 2006 25, 559-570DOI: (10.1016/j.immuni.2006.06.020) Copyright © 2006 Elsevier Inc. Terms and Conditions